Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04252014 · ClinicalTrials.gov registry record · NA
Optimizing Hookah Tobacco Public Education Messages to Reduce Young Adult Use
A NA study of Hookah Tobacco Smoking, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 830
- Enrollment target
- 1
- Study location
NCT04252014: Completed NA study of Hookah Tobacco Smoking, sponsored by Georgetown University.
NCT04252014 is a NA study of Hookah Tobacco Smoking that has completed, run by Georgetown University. The registered enrollment target is 830 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04252014, a NA study of Hookah Tobacco Smoking, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 830 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 2-arm randomized controlled trial to test the effects of hookah tobacco public education messages among young adults who are susceptible non-users of hookah tobacco and those who are current hookah tobacco users. The primary outcomes are hookah tobacco use behavior (initiation among baseline susceptible non-users, frequency of use and cessation among baseline current users) at 6-month follow-up. Secondary outcomes are curiosity to use hookah tobacco (susceptible non-users) and motivation to quit using hookah tobacco (current hookah users) measured at 6-month follow-up. These outcomes will also be measured at 2- and 4-month follow-up time points.
Primary Outcome
Hookah tobacco initiation among those who are susceptible non-users at baseline will be measured using a single valid survey question asking if participants have ever used hookah tobacco, even one or two puffs, at follow-up. The question asks if participants have ever smoked hookah tobacco based on a yes/no response. No hookah tobacco initiation is considered a better outcome. The outcome measure data reports those who responded "Yes" and are considered to have initiated hookah tobacco at the 6
Conditions Studied
Interventions
- BEHAVIORAL Hookah tobacco messages
Study Locations (1)
District of Columbia
- Georgetown University - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 830 participants |
| Start Date | 2020-02-04 |
| Est. Completion | 2022-04-30 |
| Phase | NA |
What the finished NCT04252014 record still lists
NCT04252014 is an interventional study that assigns participants to a tested intervention. The registered 830 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower).
The record links to 1 condition, with Hookah Tobacco Smoking appearing as the primary indexed condition, and to 1 intervention - of which Hookah tobacco messages is the first listed.
NCT04252014 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04252014 about?
NCT04252014 is a clinical study titled "Optimizing Hookah Tobacco Public Education Messages to Reduce Young Adult Use". This is a 2-arm randomized controlled trial to test the effects of hookah tobacco public education messages among young adults who are susceptible non-users of hookah tobacco and those who are current hookah tobacco users. The primary outcomes are hookah tobacco use behavior (initiation among baseli...
What is the current status of trial NCT04252014?
This trial is currently completed. It is a NA study. The enrollment target is 830 participants. The study started on 2020-02-04. Estimated completion is 2022-04-30.
What conditions does trial NCT04252014 study?
This clinical trial studies the following conditions: Hookah Tobacco Smoking.
What interventions are being tested in trial NCT04252014?
The interventions under investigation include: Hookah tobacco messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT04252014?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04252014 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04252014's enrollment target sits among peer trials
830 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05067283 · 830 participants · Phase 1
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
- NCT06592924 · 830 participants · Phase 3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- NCT06868277 · 830 participants · Phase 3
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
- NCT06910553 · 832 participants
IBD Pregnancy Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI